Bactericidal/permeability-increasing protein (rBPI₂₁) in patients with hemorrhage due to trauma: Results of a multicenter phase II clinical trial

Keyphrases

• Placebo Groups 100%
• Hazard Ratio 100%
• Trauma 100%
• Serious Complications 100%
• Phase II Clinical Trial 100%
• Mortality Complications 75%
• Phase II Study 50%
• Injury Severity Score 50%
• Age Groups 25%
• Blunt Trauma 25%
• Placebo 25%
• Cytokine Levels 25%
• Consecutive Days 25%
• Most Common Cause 25%
• Injury Mechanism 25%
• Trauma Patients 25%
• Mortality Rate 25%
• Pneumonia 25%
• Oxygen Radicals 25%
• Cause of Death 25%
• Organ Dysfunction 25%
• Possible Causes 25%
• Treatment Difference 25%
• Recombinant Human 25%
• Acute Respiratory Distress Syndrome 25%
• Resource Utilization 25%
• Organ Failure 25%
• Randomized Placebo-controlled Trial 25%
• Respiratory Complications 25%
• Equivalent Volume 25%
• Hemorrhagic Shock 25%
• Composite Endpoint 25%
• Drug Infusion 25%
• Antiendotoxin 25%
• Continuous Infusion 25%
• Traumatic Hemorrhage 25%
• Bacterial Translocation 25%
• Penetrating Trauma 25%
• Early Resuscitation 25%

Medicine and Dentistry

• Clinical Trial 100%
• Placebo 100%
• Injury 100%
• Bleeding 100%
• Bactericidal Permeability Increasing Protein 100%
• Hazard Ratio 66%
• Cytokine 33%
• Abbreviated Injury Scale 33%
• Infection 16%
• Antiinfective Agent 16%
• Blunt Trauma 16%
• Infusion 16%
• Resuscitation 16%
• Oxygen Radical 16%
• Acute Respiratory Distress Syndrome 16%
• Hemorrhagic Shock 16%
• Drug Infusion 16%
• Continuous Infusion 16%
• Penetrating Trauma 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Injury 100%
• Clinical Trial 100%
• Placebo 100%
• Bleeding 100%
• Bactericidal Permeability Increasing Protein 100%
• Cytokine 33%
• Injury Scale 33%
• Blunt Trauma 16%
• Infection 16%
• Antiinfective Agent 16%
• Oxygen Radical 16%
• Adult Respiratory Distress Syndrome 16%
• Hemorrhagic Shock 16%
• Penetrating Trauma 16%